89bio
Stock Forecast, Prediction & Price Target
89bio Financial Estimates
89bio Revenue Estimates
89bio EBITDA Estimates
89bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $2.5M Low: $2.5M High: $2.5M avg. 0% | Avg: $38.10M Low: $38.10M High: $38.10M avg. 1424.31% | Avg: $155.94M Low: $155.94M High: $155.94M avg. 309.21% | Avg: $462.04M Low: $462.04M High: $462.04M avg. 196.29% |
Net Income
% change YoY
| $-90.12M N/A | $-102.02M -13.20% | $-142.18M -39.36% | Avg: $-286.66M Low: $-241.98M High: $-175.08M avg. -101.61% | Avg: $-292.48M Low: $-248.39M High: $-55.51M avg. -2.02% | Avg: $-124.12M Low: $-124.12M High: $-124.12M avg. 57.56% | Avg: $-593.08K Low: $-593.08K High: $-593.08K avg. 99.52% |
EBITDA
% change YoY
| $-89.74M N/A | $-102.24M -13.93% | $-134.46M -31.50% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$4.48 N/A | -$2.93 34.59% | -$2 31.74% | Avg: -$2.84 Low: -$3.4 High: -$2.46 avg. -42.10% | Avg: -$2.62 Low: -$3.49 High: -$0.78 avg. 7.85% | Avg: -$1.74 Low: -$1.74 High: -$1.74 avg. 33.40% | Avg: -$0.01 Low: -$0.01 High: -$0.01 avg. 99.52% |
Operating Expenses
% change YoY
| $89.74M N/A | $102.24M 13.93% | $151.20M 47.87% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is 89bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 13.36% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -241.98M, average is -286.66M and high is -175.08M.
What is 89bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 482.45% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $2.5M, average is $2.5M and high is $2.5M.
What is 89bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 24.66% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$3.4, average is -$2.84 and high is $-2.46.
What is the best performing analyst?
In the last twelve months analysts have been covering 89bio stock. The most successful analyst is Eliana Merle.